Burford Brothers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Sell
9,209
-6,347
-41% -$1.48M 0.86% 28
2026
Q1
$3.8M Buy
15,556
+6,595
+74% +$1.54M 1.56% 12
2025
Q4
$1.85M Buy
8,961
+1
+0% +$198 0.77% 27
2025
Q3
$1.66M Sell
8,960
-19
-0.2% -$3.25K 0.71% 30
2025
Q2
$1.37M Sell
8,979
-8,183
-48% -$1.26M 0.63% 36
2025
Q1
$2.85M Buy
17,162
+8,214
+92% +$1.29M 1.38% 14
2024
Q4
$1.29M Sell
8,948
-7,621
-46% -$1.18M 0.64% 34
2024
Q3
$2.69M Buy
16,569
+977
+6% +$156K 1.4% 14
2024
Q2
$2.28M Buy
15,592
+404
+3% +$60.1K 1.32% 16
2024
Q1
$2.4M Buy
15,188
+6,263
+70% +$997K 1.58% 13
2023
Q4
$1.4M Buy
+8,925
New +$1.37M 0.99% 26

Other funds holding JNJ

Burford Brothers's JNJ Position: Q2 2026 in Review

Burford Brothers reduced its Johnson & Johnson (JNJ) stake by 41% in Q2 2026, selling an estimated $1.48M and leaving 9,209 shares worth $2.34M. The position accounts for 0.86% of the portfolio, ranked #28.

Burford Brothers first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.8M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Burford Brothers held 9,209 shares of Johnson & Johnson worth $2.34M as of Q2 2026.
  • Burford Brothers sold 6,347 Johnson & Johnson shares in Q2 2026, an estimated $1.48M.
  • Johnson & Johnson made up 0.86% of Burford Brothers's portfolio in Q2 2026, its #28 holding.
  • Burford Brothers first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Burford Brothers's Johnson & Johnson position peaked at $3.8M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Burford Brothers's 13F filing for Q2 2026, filed 28 Jul 2026.